Rehmann Capital Advisory Group’s Avanos Medical AVNS Stock Holding History

Rehmann Capital Advisory Group’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$3.9K	Hold	104	–	–	﹤0.01%	1273
2019 Q2	$4.54K	Hold	104	–	–	﹤0.01%	1581
2019 Q1	$4.44K	Hold	104	–	–	﹤0.01%	1562
2018 Q4	$4.66K	Sell	104 -4	-4%	-$210	﹤0.01%	1281
2018 Q3	$7.4K	Hold	108	–	–	﹤0.01%	1454
2018 Q2	$6.18K	Buy	108 +54	+100%	+$2.85K	﹤0.01%	1490
2018 Q1	$2K	Buy	+54	New	+$2.56K	﹤0.01%	1700

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Rehmann Capital Advisory Group's AVNS Position: Q3 2019 in Review

Rehmann Capital Advisory Group held its Avanos Medical (AVNS) position steady in Q3 2019 at 104 shares worth $3.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1273.

Rehmann Capital Advisory Group first reported a position in AVNS in Q1 2018 and has held it in 7 quarters since. The position peaked at $7.4K in Q3 2018. 290 funds tracked by Wall St. Rank hold AVNS as of Q3 2019.

Rehmann Capital Advisory Group held 104 shares of Avanos Medical worth $3.9K as of Q3 2019.
Rehmann Capital Advisory Group left its Avanos Medical share count unchanged in Q3 2019.
Avanos Medical made up ﹤0.01% of Rehmann Capital Advisory Group's portfolio in Q3 2019, its #1273 holding.
Rehmann Capital Advisory Group first reported a position in Avanos Medical in Q1 2018 and has held it in 7 quarters since.
Rehmann Capital Advisory Group's Avanos Medical position peaked at $7.4K in Q3 2018.
290 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2019.

Based on Rehmann Capital Advisory Group's 13F filing for Q3 2019, filed 2 Jan 2020.